A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam
An Interventional, Phase 1, Open-Label, Fixed Sequence, 2-Period Study to Estimate the Effect of Single and Multiple Doses of Vepdegestrant (ARV-471, PF-07850327) on the Pharmacokinetics of Single Dose Midazolam in Healthy Adult Females of Non-Childbearing Potential
Category & Conditions: Cancer
Medicine: VEPDEGESTRANT
ClinicalTrials.gov Identifier (NCT): NCT06256510
Protocol ID: C4891039
Report Type: Final
Language: English
Open Plain Language Summary Result:
Click here